{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:13:43Z","timestamp":1782321223351,"version":"3.54.5"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000875","name":"Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001207","name":"Esther A. and Joseph Klingenstein Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014185","name":"Searle Scholars Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.biopsych.2019.08.028","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T12:22:10Z","timestamp":1568290930000},"page":"6-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Molecular Basis of Opioid Action: From Structures to New Leads"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7173-3741","authenticated-orcid":false,"given":"Aashish","family":"Manglik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2019.08.028_bib1","article-title":"S\u00e4ure im Opium","volume":"13","author":"Sert\u00fcrner","year":"1805","journal-title":"J\u00a0Pharmacie"},{"key":"10.1016\/j.biopsych.2019.08.028_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.182.4119.1359","article-title":"Opiate agonists and antagonists discriminated by receptor binding in brain","volume":"182","author":"Pert","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.08.028_bib3","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1073\/pnas.70.7.1947","article-title":"Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate","volume":"70","author":"Simon","year":"1973","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0026-895X(25)14011-X","article-title":"Opiate receptor binding of agonists and antagonists affected differentially by sodium","volume":"10","author":"Pert","year":"1974","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/253448a0","article-title":"Differentiation of opiate agonist and antagonist receptor binding by protein modifying reagents","volume":"253","author":"Wilson","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib6","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.78.10.6181","article-title":"Classification of multiple morphine and enkephalin binding sites in the central nervous system","volume":"78","author":"Wolozin","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib7","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.08.028_bib8","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(25)13175-1","article-title":"Molecular cloning and functional expression of a mu-opioid receptor from rat brain","volume":"44","author":"Chen","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib10","doi-asserted-by":"crossref","first-page":"26447","DOI":"10.1016\/S0021-9258(19)74335-X","article-title":"Purification and partial amino acid sequence of a mu opioid receptor from rat brain","volume":"268","author":"Eppler","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0896-6273(93)90120-G","article-title":"Cloning and pharmacological characterization of a rat mu opioid receptor","volume":"11","author":"Thompson","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2019.08.028_bib12","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1073\/pnas.90.21.10230","article-title":"mu opiate receptor: cDNA cloning and expression","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: Evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2019.08.028_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2019.08.028_bib15","first-page":"79","article-title":"Constitution of codeine and thebaine","volume":"69","author":"Gulland","year":"1925","journal-title":"Mem Proc Manchester Lit Phil Soc"},{"key":"10.1016\/j.biopsych.2019.08.028_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.2042-7158.1954.tb11033.x","article-title":"Synthetic analgesics: Stereochemical considerations","volume":"6","author":"Beckett","year":"1954","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.2042-7158.1956.tb12215.x","article-title":"Analgesics and their antagonists: Some steric and chemical considerations. I. The dissociation constants of some tertiary amines and synthetic analgesics, the conformations of methadone-type compounds","volume":"8","author":"Beckett","year":"1956","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0079-6468(08)70169-3","article-title":"Analgesics and their antagonists: Biochemical aspects and structure-activity relationships","volume":"4","author":"Beckett","year":"1965","journal-title":"Prog Med Chem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acs.chemrev.6b00177","article-title":"GPCR dynamics: Structures in motion","volume":"117","author":"Latorraca","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.biopsych.2019.08.028_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrm3933","article-title":"Methodological advances: The unsung heroes of the GPCR structural revolution","volume":"16","author":"Ghosh","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11111","article-title":"Structure of the delta-opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the micro-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature11085","article-title":"Structure of the nociceptin\/orphanin FQ receptor in complex with a peptide mimetic","volume":"485","author":"Thompson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10939","article-title":"Structure of the human kappa-opioid receptor in complex with JDTic","volume":"485","author":"Wu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.2965","article-title":"Structural basis for bifunctional peptide recognition at human \u03b4-opioid receptor","volume":"22","author":"Fenalti","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the micro-opioid receptor-Gi protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.2042-7158.1990.tb05428.x","article-title":"The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors","volume":"42","author":"Rogers","year":"1990","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(00)00578-1","article-title":"Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop","volume":"403","author":"Bonner","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0026-895X(25)10670-6","article-title":"Selective enhancement of [3H]opiate agonist binding by divalent cations","volume":"11","author":"Pasternak","year":"1975","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature12944","article-title":"Molecular control of delta-opioid receptor signalling","volume":"506","author":"Fenalti","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib31","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/bph.14602","article-title":"The delta-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist","volume":"176","author":"Stanczyk","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acschembio.5b00712","article-title":"Proposed mode of binding and action of positive allosteric modulators at opioid receptors","volume":"11","author":"Shang","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib33","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/1087057114542975","article-title":"Identification of selective agonists and positive allosteric modulators for micro- and delta-opioid receptors from a single high-throughput screen","volume":"19","author":"Burford","year":"2014","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.biopsych.2019.08.028_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neulet.2018.02.037","article-title":"Insights from molecular dynamics simulations to exploit new trends for the development of improved opioid drugs","volume":"700","author":"Filizola","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.08.028_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/07391102.2017.1417914","article-title":"Molecular mechanisms of allosteric probe dependence in mu opioid receptor","volume":"37","author":"Bartuzi","year":"2019","journal-title":"J\u00a0Biomol Struct Dyn"},{"key":"10.1016\/j.biopsych.2019.08.028_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.117.109561","article-title":"Pharmacologic evidence for a putative conserved allosteric site on opioid receptors","volume":"93","author":"Livingston","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tips.2018.05.001","article-title":"PAM-antagonists: A better way to block pathological receptor signaling?","volume":"39","author":"Kenakin","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2019.08.028_bib38","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2015.04.043","article-title":"Structural insights into the dynamic process of beta2-adrenergic receptor signaling","volume":"161","author":"Manglik","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.08.028_bib39","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1021\/acs.biochem.7b00747","article-title":"Structural basis for G protein-coupled receptor activation","volume":"56","author":"Manglik","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopsych.2019.08.028_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature09648","article-title":"Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor","volume":"469","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth.1526","article-title":"Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins","volume":"7","author":"Chae","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.biopsych.2019.08.028_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.sbi.2011.06.011","article-title":"Nanobody stabilization of G protein-coupled receptor conformational states","volume":"21","author":"Steyaert","year":"2011","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-pharmtox-010716-104710","article-title":"Nanobodies to study G protein-coupled receptor structure and function","volume":"57","author":"Manglik","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into micro-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib45","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/0960-894X(95)00522-1","article-title":"Morphinan cyclic imines and pyrrolidines containing a constrained phenyl group: High affinity opioid agonists","volume":"5","author":"Husbands","year":"1995","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.biopsych.2019.08.028_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","article-title":"Structure and dynamics of GPCR signaling complexes","volume":"25","author":"Hilger","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib47","series-title":"The Delta Receptor","article-title":"Binding and activity of opioid ligands at the cloned human delta, mu, and kappa receptors","author":"Payza","year":"2003"},{"key":"10.1016\/j.biopsych.2019.08.028_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0014-2999(99)00460-4","article-title":"Differential binding properties of oripavines at cloned mu- and delta-opioid receptors","volume":"378","author":"Lee","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","article-title":"Structure of the nanobody-stabilized active state of the kappa opioid receptor","volume":"172","author":"Che","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.08.028_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tcb.2018.06.002","article-title":"Illuminating GPCR signaling by cryo-EM","volume":"28","author":"Safdari","year":"2018","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib51","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1038\/s41467-018-06002-w","article-title":"Development of an antibody fragment that stabilizes GPCR\/G-protein complexes","volume":"9","author":"Maeda","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2019.08.028_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the beta2 adrenergic receptor-Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-018-0259-z","article-title":"Structural insights into G-protein-coupled receptor allostery","volume":"559","author":"Thal","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib54","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.08.028_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrd.2018.180","article-title":"GPCR drug discovery: Integrating solution NMR data with crystal and cryo-EM structures","volume":"18","author":"Shimada","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2019.08.028_bib56","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1073\/pnas.1510117112","article-title":"NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor","volume":"112","author":"O'Connor","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nature14680","article-title":"Propagation of conformational changes during mu-opioid receptor activation","volume":"524","author":"Sounier","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cell.2013.01.008","article-title":"The dynamic process of beta(2)-adrenergic receptor activation","volume":"152","author":"Nygaard","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.08.028_bib59","doi-asserted-by":"crossref","first-page":"15771","DOI":"10.1002\/anie.201508794","article-title":"Identification of a conformational equilibrium that determines the efficacy and functional selectivity of the mu-opioid receptor","volume":"54","author":"Okude","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.biopsych.2019.08.028_bib60","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A\u00a0G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2019.08.028_bib61","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41589-018-0145-x","article-title":"Structural insights into binding specificity, efficacy and bias of a beta2AR partial agonist","volume":"14","author":"Masureel","year":"2018","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib62","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41467-017-02008-y","article-title":"Insight into partial agonism by observing multiple equilibria for ligand-bound and Gs-mimetic nanobody-bound beta1-adrenergic receptor","volume":"8","author":"Solt","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2019.08.028_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature22354","article-title":"Single-molecule analysis of ligand efficacy in beta2AR-G-protein activation","volume":"547","author":"Gregorio","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib64","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ncomms2046","article-title":"Efficacy of the beta(2)-adrenergic receptor is determined by conformational equilibrium in the transmembrane region","volume":"3","author":"Kofuku","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2019.08.028_bib65","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1021\/acs.biochem.6b00948","article-title":"How oliceridine (TRV-130) binds and stabilizes a mu-opioid receptor conformational state that selectively triggers G protein signaling pathways","volume":"55","author":"Schneider","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopsych.2019.08.028_bib66","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/jacs.7b12191","article-title":"Markov state models: From an art to a science","volume":"140","author":"Husic","year":"2018","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.biopsych.2019.08.028_bib67","article-title":"Kinetic machine learning unravels ligand-directed conformational change of \u03bc opioid receptor [published online ahead of print July 31]","author":"Feinberg","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopsych.2019.08.028_bib68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","article-title":"Are \u03bc-opioid receptor polymorphisms important for clinical opioid therapy?","volume":"11","author":"L\u00f6tsch","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.biopsych.2019.08.028_bib69","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1074\/jbc.M807030200","article-title":"A\u00a0common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain","volume":"284","author":"Oertel","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib70","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2004.02340.x","article-title":"Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor","volume":"89","author":"Beyer","year":"2004","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/tpj.2014.59","article-title":"Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents","volume":"15","author":"Chidambaran","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.biopsych.2019.08.028_bib72","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0000000000000405","article-title":"OPRM1 A118G gene variant and postoperative opioid requirement: A systematic review and meta-analysis","volume":"121","author":"Hwang","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2019.08.028_bib73","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.1073\/pnas.0812612106","article-title":"Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection","volume":"106","author":"Way","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib74","doi-asserted-by":"crossref","first-page":"10811","DOI":"10.1073\/pnas.0904509106","article-title":"Functional characterization of human variants of the mu-opioid receptor gene","volume":"106","author":"Ravindranathan","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.biopsych.2019.08.028_bib75","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/1096-8628(20001009)96:5<604::AID-AJMG5>3.0.CO;2-F","article-title":"Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: Potential in studies of addiction","volume":"96","author":"LaForge","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.biopsych.2019.08.028_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2017.11.033","article-title":"Pharmacogenomics of GPCR drug targets","volume":"172","author":"Hauser","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.08.028_bib77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and regulation of alternative pre-mRNA splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib78","doi-asserted-by":"crossref","first-page":"19778","DOI":"10.1073\/pnas.1115231108","article-title":"Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects","volume":"108","author":"Majumdar","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.biopsych.2019.08.028_bib79","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1213\/ANE.0000000000002538","article-title":"Truncated mu-opioid receptors with 6 transmembrane domains are essential for opioid analgesia","volume":"126","author":"Lu","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.biopsych.2019.08.028_bib80","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1172\/JCI81070","article-title":"Mediation of opioid analgesia by a truncated 6-transmembrane GPCR","volume":"125","author":"Lu","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.biopsych.2019.08.028_bib81","doi-asserted-by":"crossref","first-page":"26732","DOI":"10.1074\/jbc.M109.026922","article-title":"Purification and functional reconstitution of monomeric mu-opioid receptors: Allosteric modulation of agonist binding by Gi2","volume":"284","author":"Kuszak","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib82","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1111\/bph.12798","article-title":"Revolution in GPCR signalling: Opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10","volume":"171","author":"Fujita","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib83","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1038\/s41598-018-26070-8","article-title":"Molecular details of dimerization kinetics reveal negligible populations of transient micro-opioid receptor homodimers at physiological concentrations","volume":"8","author":"Meral","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2019.08.028_bib84","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/bph.13441","article-title":"Biased ligand quantification in drug discovery: From theory to high throughput screening to identify new biased mu opioid receptor agonists","volume":"173","author":"Winpenny","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib85","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1021\/jm4010829","article-title":"Structure-activity relationships and discovery of a G protein biased mu opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan- 9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain","volume":"56","author":"Chen","year":"2013","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib86","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nchembio.2490","article-title":"Discovery of new GPCR ligands to illuminate new biology","volume":"13","author":"Roth","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.biopsych.2019.08.028_bib87","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: A powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.biopsych.2019.08.028_bib88","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","article-title":"Ultra-large library docking for discovering new chemotypes","volume":"566","author":"Lyu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib89","doi-asserted-by":"crossref","first-page":"E2419","DOI":"10.1073\/pnas.1718037115","article-title":"Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor","volume":"115","author":"Korczynska","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.08.028_bib90","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tips.2012.03.007","article-title":"Structure-based drug screening for G-protein-coupled receptors","volume":"33","author":"Shoichet","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2019.08.028_bib91","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1021\/ci400019t","article-title":"Discovery of a novel selective kappa-opioid receptor agonist using crystal structure-based virtual screening","volume":"53","author":"Negri","year":"2013","journal-title":"J\u00a0Chem Inf Model"},{"key":"10.1016\/j.biopsych.2019.08.028_bib92","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1021\/acs.jmedchem.7b00109","article-title":"Structure-based discovery of new antagonist and biased agonist chemotypes for the kappa opioid receptor","volume":"60","author":"Zheng","year":"2017","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2019.08.028_bib93","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.08.028_bib94","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A\u00a0nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319316695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319316695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:03:50Z","timestamp":1757775830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322319316695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0006322319316695"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.08.028","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Basis of Opioid Action: From Structures to New Leads","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}